ArticleThe Journal of experimental medicine2026

Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

Ian M Delahunty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.